广东医科大学中美学者论坛2025学术交流会
发布日期：2025-09-09 作者：实验室管理办公室 来源： 点击：
Jan Vijg is Professor and Chairman of the Department of Genetics at the Albert Einstein College of Medicine in New York since July 2008. He received his PhD from the University of Leiden, The Netherlands, in 1987, and moved to the US in 1993. He was an Associate Professor at Harvard Medical School from 1993 to 1999, a Professor at the University of Texas Health Science Center in San Antonio from 1999 to 2005, and a Professor at the Buck Institute for Research on Aging in Novato, CA, from 2005 to 2008.
With his research team he was the first to develop transgenic mouse models for studying somatic mutations in different organs and tissues (in 1989), one of which (MutaMouse) became the industry standard in genetic toxicology testing. His lab used these mouse models to demonstrate an age-related increase in somatic mutations for most tissues, as well as tissue-specificities in the types of mutations accumulating, from base substitutions to large genome rearrangements. Since 2007 he has developed single-cell and single-molecule methods for studying somatic mutations and epimutations in relation to aging and disease. Using these methods, he demonstrated that, also in humans, somatic mutations accumulate with age in a tissue-specific manner. Dr. Vijg’s research has been continuously funded by the US National Institutes of Health since 1994. He has published over 300 scientific articles and three books. Yousin Suh is Charles and Marie Robertson professor of Reproductive Sciences in OB&GNY, Professor of Genetics and Development, and Director of Reproductive Aging at Columbia University. She investigates the (epi)genetic component that underlies the interface of intrinsic aging and disease based on identifying (epi)genome sequence variants associated with age-related disease risk or its opposite. She has published over 100 papers (Nat Rev Mol cell Biol, Nat Aging, Neuron, PNAs, et al.) and received the Glenn Award for Research in Biological Mechanisms of Aging, along with extensive contributions to scientific community by organizing numerous international symposiums.
周中军, 男，博士，香港大学李嘉诚医学院生物医学学院终身教授，Chui Fook-Cheun 分子医学冠名教授, 广东医科大学衰老研究领域首席科学家。亚洲衰老研究学会创会主席。1988年毕业于厦门大学，获理学学士学位，1993年毕业于中国医学科学院、中国协和医科大学，获博士学位。1996年至2002年留学瑞典卡罗林斯卡医学院（Karolinska Institute），并获瑞典卡罗林斯卡医学院博士学位。2002年12月起，在香港大学生物化学与分子生物学系任职至今。长期从事罕见病、发育、核基质，染色质结构调控，衰老及衰老相关疾病研究。在包括Nature、Nature Genetics、Nature Medicine、Cell Stem Cell、Cell Metabolism、Dev Cell、Nature Communication、Science Adv、Nature Metabolism、EMBO J、PNAS、eLife，Cell Reports、Cancer Res、J Cell Biol，JCI Insights、Nuclear Acid Res等国际重要学术期刊发表高水平学术论文。担任国际学术期刊“Mutation Research”和 “Frontier in Aging” 副主编，“Translational Medicine of Aging”主编，“Aging Cell”编委。熊兴东：三级教授，博士生导师，博士后合作导师，广东省扬帆计划高层次人才，广东省高校“千百十工程”省级培养对象，南粤优秀教师，衰老与抗衰老省级创新团队负责人，东莞市特支计划科技创新领军人才，东莞市特色人才（三类），东莞市衰老与抗衰老重点实验室主任，广东医科大学学报编辑部主任，广东医科大学附属东莞第一医院心血管中心学术主任，广东医科大学欧美同学会（留学人员联谊会）会长。兼任中国老年学和老年医学学会抗衰老分会常委，中国生物化学与分子生物学会基础医学专业分会委员，中国研究型医院学会细胞外囊泡研究与应用专业委员会委员，广东省生物化学与分子生物学学会常务理事，广东省精准医学应用学会细胞外囊泡分会常委，广东省科学技术期刊编辑学会医学期刊分会副主任委员。主要从事血管内皮功能障碍与动脉粥样硬化的基础及应用转化研究，主持国家自然科学基金5项，广东省自然科学基金等省级课题5项（含重点项目1项）。获授权国家发明专利4件。以第一作者或通讯作者在Drug Resist Update、Aging Cell、Oncogene、Mol Ther-Nucleic Acids、Aging Dis、Genes Dis、J Mol Cell Cardiol等学术期刊上发表SCI论文51篇，入选全国老年医学领域专家国际论文学术影响力百强。
李雪萌，广东医科大学高层次人才；广东省青年珠江学者，东莞市特色人才，湛江市人体微生态与临床转化重点实验室主任，现任广东省免疫学会老年医学专委会常务委员；广东省医学会老年医学分会老年基础研究学组委员。主要从事微生物学挖掘及医学检测的相关研究。研究具体包括（1）肠道菌群组学分析，尤其在长寿或衰老人群；（2）细菌分离培养及功能鉴定；已主持国家自然基金、广东省科技计划、广东省面上项目等多项国家与省市级项目。目前共发表相关SCI论文18篇，以第一作者或通讯作者在Advanced Materials（IF: 30.8）、iMeta(IF：23.8)、Analytical Chemistry（IF 6.785）和Sensors & Actuators B-Chemical（IF 7.100）等发表论文11篇，累加影响因子 110分。授权发明专利2项。
